首页> 外文期刊>Neuroscience Letters: An International Multidisciplinary Journal Devoted to the Rapid Publication of Basic Research in the Brain Sciences >GBA RNAi but not catalytic inhibition of glucocerebrosidase with Conduritol-beta-epoxide increases levels of total alpha-synuclein in SH-SY5Y cells
【24h】

GBA RNAi but not catalytic inhibition of glucocerebrosidase with Conduritol-beta-epoxide increases levels of total alpha-synuclein in SH-SY5Y cells

机译:GBA RNAI但不催化抑制葡萄糖脑苷酶,CONCURINOL-β-环氧化物增加了SH-SY5Y细胞中总α-突触核蛋白的水平

获取原文
获取原文并翻译 | 示例
       

摘要

Mutations in the glucocerebrosidase gene are a common genetic risk factor for developing Parkinson's disease. The reasons why glucocerebrosidase mutations cause an increased life-time risk of developing Parkinson's disease are not fully understood. Here, we aimed to verify whether glucocerebrosidase activity has an effect on total alpha-synuclein levels. We use SH-SY5Y and primary cortical cells and expose them to either Conduritol-beta-epoxide or siRNA targeting GBA 1. Unexpectedly, RNA interference towards GBA 1 and catalytic inhibition produce different effects on alpha-synuclein levels in cellular models.
机译:葡萄糖纤维素酶基因中的突变是发展帕金森病的常见遗传危险因素。 葡萄糖纤维素酶突变导致培养帕金森病的寿命风险增加的原因尚不完全理解。 在这里,我们旨在验证葡萄糖苷酶活性是否对总α-突触核蛋白水平的影响。 我们使用SH-SY5Y和初级皮质细胞并将其暴露于靶向GBA的Concuritol-β-环氧化物或siRNA 1.意外地,对GBA 1和催化抑制的RNA干扰对细胞模型中的α-突触核蛋白水平产生不同的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号